시장보고서

상품코드

1831693

스마트 흡입기 시장 : 시장 규모, 점유율, 동향, 산업 분석 보고서 - 유형별, 적응증별, 유통 채널별, 최종 용도별, 지역별, 시장 예측(2025-2034년)

Smart Inhalers Market Size, Share, Trend, Industry Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhaler), By Indication, By Distribution Channel, By End Use, By Region - Market Forecast, 2025-2034

발행일: 2025년 09월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 126 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 스마트 흡입기 시장 규모는 2034년까지 1,089억 6,000만 달러에 이를 것으로 예측됩니다. 이 보고서는 현재 시장 역학을 상세하게 파악하고 미래 시장 성장에 대한 분석을 제공합니다.

스마트 흡입기 시장은 호흡기 질환 관리를 개선하기 위해 약물 전달 장치와 연결 기술을 결합한 디지털 건강 내에서 빠르게 진화하는 부문을 나타냅니다. 이 흡입기는 센서와 무선 통신을 통합하여 사용 패턴을 모니터링하고, 어드히어런스를 추적하며, 환자와 의료 제공업체에게 실시간 피드백을 제공합니다. 천식과 만성 폐색성 폐질환(COPD)의 부담 증가가 시장을 견인하고 있으며, 효과적인 치료에는 복약 준수와 올바른 흡입 기술이 필수적입니다. 환자 중심의 헬스케어에 대한 주목 증가, 원격 모니터링에 대한 수요 증가, 흡입기 시스템에 인공지능의 통합이 채택을 강화하고 있습니다. 업계 동향은 임상 결과 및 환자 참여를 모두 강화하는 솔루션을 공동 개발하기 위한 제약 회사와 디지털 건강 기술 제공업체와의 강력한 협력 관계를 강조합니다. 클라우드 플랫폼 및 모바일 애플리케이션의 통합은 데이터 중심의 치료 개인화와 의사 및 환자의 커뮤니케이션 개선을 가능하게 하여 비즈니스 기회를 확대하고 있습니다.

디지털 치료제에 대한 규제 당국의 지원과 커넥티드 디바이스에 대한 상환 모델이 시장 성장을 강화하고 있습니다. 게다가 가치 기반 헬스케어 모델의 확대는 입원을 줄이고 자원 이용을 최적화하는 기술의 채용을 의료 제공업체에게 촉구하고 있습니다. 예방 케어와 자기 관리 도구를 중시하는 경향이 강해지고 있는 것도, 스마트 흡입기를 장기적인 질병 관리 전략에 있어서 필수적인 요소로서 자리매김하고 있습니다. 소형화 센서, 머신러닝 알고리즘 및 연결 표준의 지속적인 진보는 미래의 혁신에 큰 잠재력을 제시하여 스마트 흡입기 시장이 건강 에코시스템 전반에 걸쳐 강력한 투자와 전략적 파트너십을 유치하도록 보장합니다.

스마트 흡입기 시장 보고서 하이라이트

유형별로, 정량 흡입기(MDI) 부문은 2024년 매출 점유율의 65%를 차지했으며 시장을 독점했습니다. 이 이점은 널리 사용 가능하고 사용하기 쉽기 때문입니다.

적응증별로는 COPD 부문이 2024년에 60%의 최대 수익 점유율을 차지했으며, 고령화 사회에서 만성 호흡기 질환의 부담 증가가 그 요인이 되고 있습니다.

북미의 스마트 흡입기 시장은 천식과 COPD의 높은 유병률, 확립된 헬스케어 인프라, 고급 디지털 헬스 솔루션의 채용 확대로 최대의 수익 점유율 45%를 차지했습니다.

아시아태평양 시장은 헬스케어 의식 증가, 호흡기 질환 유병률 증가, 디지털 건강 생태계의 급속한 확대로 2025-2034년 가장 높은 CAGR을 나타낼 것으로 예측됩니다.

세계 주요 기업은 3M, adherium, AireHealth, Inc., Amiko Digital Health Limited., Cognita Labs, COHERO Health Inc. AptarGroup, Inc., FindAir Sp. z o.o., Novartis AG, Personal Air Quality Systems Pvt Ltd., Pneuma Respiratory Inc., Presspart Verwaltungs GmbH., Propeller Health(ResMed), Teva Pharmaceuticals Industries Ltd. 등이 있습니다.

시장 현황
스마트 흡입기 시장 역학
- 성장 촉진요인 및 기회
  - 호흡기 질환의 유병률 상승
  - 정부 및 규제 당국의 지원
- 성장 억제요인 및 과제
  - 장치 비용이 높고 환불 정책이 없기 때문에 특히 저소득 시장과 신흥 시장에서는 광범위한 배포 제한
PESTEL 분석
스마트 흡입기 시장의 파워 평가의 동향
밸류체인 분석

제5장 스마트 흡입기 시장 : 유형별

주요 조사 결과
서문
드라이 파우더 흡입기(DPI)
정량 분무식 흡입기(MDI)

제6장 스마트 흡입기 시장 : 적응증별

주요 조사 결과
서문
천식
COPD
기타

제7장 스마트 흡입기 시장 : 유통 채널별

주요 조사 결과
서문
병원 약국
소매 약국
온라인 약국

제8장 스마트 흡입기 시장 : 용도별

주요 조사 결과
서문
병원 및 진료소
스포츠 연구소
재택 케어
기타

제9장 스마트 흡입기 시장 : 지역별

주요 조사 결과
서문
- 스마트 흡입기 시장 분석 : 지역별(2020-2034년)
북미
- 북미 : 유형별(2020-2034년)
- 북미 : 적응증별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 북미 : 유통 채널별(2020-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 유형별(2020-2034년)
- 유럽 : 적응증별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 유럽 : 유통 채널별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 적응증별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 아시아태평양 : 유통 채널별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 적응증별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 중동 및 아프리카 : 유통 채널별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 유형별(2020-2034년)
- 라틴아메리카 : 적응증별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 라틴아메리카 : 유통 채널별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

확대 및 인수 분석
- 확대
- 인수
제휴, 협업, 합의 및 공개

제11장 기업 프로파일

3M
adherium
AireHealth, Inc.
Amiko Digital Health Limited.
Cognita Labs
COHERO Health Inc.(AptarGroup, Inc.)
FindAir Sp. z oo
Novartis AG
Personal Air Quality Systems Pvt Ltd
Presspart Verwaltungs GmbH.
Propeller Health(ResMed)
Pneuma Respiratory Inc.
Teva Pharmaceuticals Industries Ltd.

AJY 25.10.22

The smart inhalers market size is expected to reach USD 108.96 billion by 2034, according to a new study by Polaris Market Research. The report "Smart Inhalers Market Size, Share, Trend, Industry Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhaler), By Indication, By Distribution Channel, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The smart inhalers market represents a rapidly evolving segment within digital health, combining drug delivery devices with connected technologies to improve respiratory disease management. These inhalers integrate sensors and wireless communication to monitor usage patterns, track adherence, and provide real-time feedback to patients and healthcare providers. The market is driven by the growing burden of asthma and chronic obstructive pulmonary disease (COPD), where medication adherence and correct inhalation techniques are critical for effective treatment. Increasing focus on patient-centric healthcare, rising demand for remote monitoring, and the integration of artificial intelligence into inhaler systems are reinforcing adoption. Industry trends highlight strong collaborations between pharmaceutical companies and digital health technology providers to co-develop solutions that enhance both clinical outcomes and patient engagement. Opportunities are expanding through the integration of cloud platforms and mobile applications, enabling data-driven treatment personalization and improved physician-patient communication.

Regulatory support for digital therapeutics and reimbursement models for connected devices are strengthening market growth. Moreover, the expansion of value-based healthcare models is pushing providers to adopt technologies that reduce hospitalizations and optimize resource utilization. Growing emphasis on preventative care and self-management tools is also positioning smart inhalers as essential components in long-term disease management strategies. Continuous advancements in miniaturized sensors, machine learning algorithms, and connectivity standards present significant potential for future innovation, ensuring that the smart inhalers market continues to attract strong investment and strategic partnerships across the healthcare ecosystem.

Smart Inhalers Market Report Highlights

By type, the metered dose inhalers (MDIs) segment dominated the market with ~65% of the revenue share in 2024. The dominance is driven by their widespread availability and ease of use.

Based on indication, the COPD segment held the largest revenue share of ~60% in 2024, fueled by the growing burden of chronic respiratory diseases among the aging population.

The North America smart inhalers market accounted for the largest revenue share of ~45% due to high prevalence of asthma and COPD, well-established healthcare infrastructure, and growing adoption of advanced digital health solutions.

The market in Asia Pacific is expected to register the highest CAGR from 2025 to 2034 due to rising healthcare awareness, increasing prevalence of respiratory diseases, and rapid expansion of digital health ecosystems.

A few global key players include 3M; adherium; AireHealth, Inc.; Amiko Digital Health Limited.; Cognita Labs; COHERO Health Inc. (AptarGroup, Inc.); FindAir Sp. z o.o; Novartis AG; Personal Air Quality Systems Pvt Ltd; Pneuma Respiratory Inc.; Presspart Verwaltungs GmbH.; Propeller Health (ResMed); and Teva Pharmaceuticals Industries Ltd.

Polaris Market Research has segmented the market report on the basis of type, indication, distribution channel, end use, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Dry Powdered Inhalers (DPIs)

Metered Dose Inhalers (MDIs)

By Indication Outlook (Revenue, USD Billion, 2020-2034)

Asthma

COPD

Others

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals and Clinics

Sports Institutes

Home Care

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Smart Inhalers Market Insights

4.1. Smart Inhalers Market - Market Snapshot
4.2. Smart Inhalers Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Respiratory Diseases
  - 4.2.1.2. Government and Regulatory Support
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High device costs and lack of reimbursement policies limit widespread adoption, especially in low-income and emerging markets.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Smart Inhalers Market Power Rating Trends
4.6. Value Chain Analysis

5. Smart Inhalers Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Smart Inhalers Market, by Type, 2020-2034 (USD Billion)
5.3. Dry Powdered Inhalers (DPIs)
- 5.3.1. Smart Inhalers Market, by Dry Powdered Inhalers (DPIs), by Region, 2020-2034 (USD Billion)
5.4. Metered Dose Inhalers (MDIs)
- 5.4.1. Smart Inhalers Market, by Metered Dose Inhalers (MDIs), by Region, 2020-2034 (USD Billion)

6. Smart Inhalers Market, by Indication

6.1. Key Findings
6.2. Introduction
- 6.2.1. Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
6.3. Asthma
- 6.3.1. Smart Inhalers Market, by Asthma, by Region, 2020-2034 (USD Billion)
6.4. COPD
- 6.4.1. Smart Inhalers Market, by COPD, by Region, 2020-2034 (USD Billion)
6.5. Others
- 6.5.1. Smart Inhalers Market, by Others, by Region, 2020-2034 (USD Billion)

7. Smart Inhalers Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
7.3. Hospital Pharmacies
- 7.3.1. Smart Inhalers Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
7.4. Retail Pharmacies
- 7.4.1. Smart Inhalers Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
7.5. Online Pharmacies
- 7.5.1. Smart Inhalers Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)

8. Smart Inhalers Market, by End Use

8.1. Key Findings
8.2. Introduction
- 8.2.1. Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
8.3. Hospitals and Clinics
- 8.3.1. Smart Inhalers Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Billion)
8.4. Sports Institutes
- 8.4.1. Smart Inhalers Market, by Sports Institutes, by Region, 2020-2034 (USD Billion)
8.5. Home Care
- 8.5.1. Smart Inhalers Market, by Home Care, by Region, 2020-2034 (USD Billion)
8.6. Others
- 8.6.1. Smart Inhalers Market, by Others, by Region, 2020-2034 (USD Billion)

9. Smart Inhalers Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Smart Inhalers Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Smart Inhalers Market - North America
- 9.3.1. North America: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
- 9.3.3. North America: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
- 9.3.4. North America: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.3.5. Smart Inhalers Market - US
  - 9.3.5.1. US: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.3.6. Smart Inhalers Market - Canada
  - 9.3.6.1. Canada: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
9.4. Smart Inhalers Market - Europe
- 9.4.1. Europe: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
- 9.4.3. Europe: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
- 9.4.4. Europe: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.5. Smart Inhalers Market - UK
  - 9.4.5.1. UK: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.6. Smart Inhalers Market - France
  - 9.4.6.1. France: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.7. Smart Inhalers Market - Germany
  - 9.4.7.1. Germany: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.8. Smart Inhalers Market - Italy
  - 9.4.8.1. Italy: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.9. Smart Inhalers Market - Spain
  - 9.4.9.1. Spain: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.10. Smart Inhalers Market - Netherlands
  - 9.4.10.1. Netherlands: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.11. Smart Inhalers Market - Russia
  - 9.4.11.1. Russia: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.4.12. Smart Inhalers Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
9.5. Smart Inhalers Market - Asia Pacific
- 9.5.1. Asia Pacific: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.5. Smart Inhalers Market - China
  - 9.5.5.1. China: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.6. Smart Inhalers Market - India
  - 9.5.6.1. India: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.7. Smart Inhalers Market - Malaysia
  - 9.5.7.1. Malaysia: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.8. Smart Inhalers Market - Japan
  - 9.5.8.1. Japan: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.9. Smart Inhalers Market - Indonesia
  - 9.5.9.1. Indonesia: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.10. Smart Inhalers Market - South Korea
  - 9.5.10.1. South Korea: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.11. Smart Inhalers Market - Australia
  - 9.5.11.1. Australia: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.5.12. Smart Inhalers Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
9.6. Smart Inhalers Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.5. Smart Inhalers Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.6. Smart Inhalers Market - UAE
  - 9.6.6.1. UAE: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.7. Smart Inhalers Market - Israel
  - 9.6.7.1. Israel: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.8. Smart Inhalers Market - South Africa
  - 9.6.8.1. South Africa: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.6.9. Smart Inhalers Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
9.7. Smart Inhalers Market - Latin America
- 9.7.1. Latin America: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.7.5. Smart Inhalers Market - Mexico
  - 9.7.5.1. Mexico: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.7.6. Smart Inhalers Market - Brazil
  - 9.7.6.1. Brazil: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.7.7. Smart Inhalers Market - Argentina
  - 9.7.7.1. Argentina: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.7.8. Smart Inhalers Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Smart Inhalers Market, By Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Smart Inhalers Market, By Indication, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Smart Inhalers Market, by End Use, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Smart Inhalers Market, by Distribution Channel, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. 3M
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. adherium
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. AireHealth, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Amiko Digital Health Limited.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Cognita Labs
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. COHERO Health Inc. (AptarGroup, Inc.)
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. FindAir Sp. z o.o
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Novartis AG
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Personal Air Quality Systems Pvt Ltd
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Presspart Verwaltungs GmbH.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Propeller Health (ResMed)
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Pneuma Respiratory Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Teva Pharmaceuticals Industries Ltd.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development